ARAZIE v. AUROBINDO PHARMA, LTD. et al
| RENEE ARAZIE |
| AUROBINDO PHARMA LTD., MYLAN LABORATORIES LTD., MYLAN N.V., ZHEIJANG HUAHAI PHARMACEUTICAL CO., LTD., JOHN DOE, ACTAVIS LLC, ACTAVIS PHARMA, INC., AUROBINDO PHARMA USA, INC., HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and CVS PHARMACY, INC. |
| 1:2022cv04219 |
| June 23, 2022 |
| US District Court for the District of New Jersey |
| Robert B Kugler |
| Personal Inj. Prod. Liability |
| 28 U.S.C. ยง 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 23, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 1 COMPLAINT against All Defendants ( Filing and Admin fee $ 402 receipt number ANJDC-13509154) with JURY DEMAND, filed by RENEE ARAZIE. (Attachments: #1 Civil Cover Sheet)(WILLIAMSON, GEORGE) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
